The Oncologist,
The use of a therapeutic cancer vaccine that stimulates the immune system to fight brachyury-expressing cancer cells is a…
Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable Chordoma
Overview of attention for article published in Oncologist, March 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (78th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (61st percentile)
Readers on
- mendeley
- 69 Mendeley